245 related articles for article (PubMed ID: 30149300)
41. Chromatographic tools for plant-derived recombinant antibodies purification and characterization.
Temporini C; Colombo R; Calleri E; Tengattini S; Rinaldi F; Massolini G
J Pharm Biomed Anal; 2020 Feb; 179():112920. PubMed ID: 31706629
[TBL] [Abstract][Full Text] [Related]
42. Study of different HILIC, mixed-mode, and other aqueous normal-phase approaches for the liquid chromatography/mass spectrometry-based determination of challenging polar pesticides.
Vass A; Robles-Molina J; Pérez-Ortega P; Gilbert-López B; Dernovics M; Molina-Díaz A; García-Reyes JF
Anal Bioanal Chem; 2016 Jul; 408(18):4857-69. PubMed ID: 27178548
[TBL] [Abstract][Full Text] [Related]
43. Native Hydrophobic Interaction Chromatography Hyphenated to Mass Spectrometry for Characterization of Monoclonal Antibody Minor Variants.
Wei B; Han G; Tang J; Sandoval W; Zhang YT
Anal Chem; 2019 Dec; 91(24):15360-15364. PubMed ID: 31747256
[TBL] [Abstract][Full Text] [Related]
44. Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection.
Stoll D; Danforth J; Zhang K; Beck A
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():51-60. PubMed ID: 27267072
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive Two-Dimensional Hydrophilic Interaction Chromatography (HILIC) × Reversed-Phase Liquid Chromatography Coupled to High-Resolution Mass Spectrometry (RP-LC-UV-MS) Analysis of Anthocyanins and Derived Pigments in Red Wine.
Willemse CM; Stander MA; Vestner J; Tredoux AG; de Villiers A
Anal Chem; 2015 Dec; 87(24):12006-15. PubMed ID: 26554292
[TBL] [Abstract][Full Text] [Related]
46. Alternative mobile phase additives for the characterization of protein biopharmaceuticals in liquid chromatography - Mass spectrometry.
Lardeux H; Duivelshof BL; Colas O; Beck A; McCalley DV; Guillarme D; D'Atri V
Anal Chim Acta; 2021 Apr; 1156():338347. PubMed ID: 33781463
[TBL] [Abstract][Full Text] [Related]
47. High-Resolution Capillary Zone Electrophoresis with Mass Spectrometry Peptide Mapping of Therapeutic Proteins: Peptide Recovery and Post-translational Modification Analysis in Monoclonal Antibodies and Antibody-Drug Conjugates.
Dada OO; Zhao Y; Jaya N; Salas-Solano O
Anal Chem; 2017 Nov; 89(21):11236-11242. PubMed ID: 28984442
[TBL] [Abstract][Full Text] [Related]
48. The versatility of heart-cutting and comprehensive two-dimensional liquid chromatography in monoclonal antibody clone selection.
Sandra K; Steenbeke M; Vandenheede I; Vanhoenacker G; Sandra P
J Chromatogr A; 2017 Nov; 1523():283-292. PubMed ID: 28668371
[TBL] [Abstract][Full Text] [Related]
49. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
[TBL] [Abstract][Full Text] [Related]
50. Harnessing the power of electrophoresis and chromatography: Offline coupling of reverse phase liquid chromatography-capillary zone electrophoresis-tandem mass spectrometry for peptide mapping for monoclonal antibodies.
Kumar R; Shah RL; Rathore AS
J Chromatogr A; 2020 Jun; 1620():460954. PubMed ID: 32063275
[TBL] [Abstract][Full Text] [Related]
51. Chromatography and its hyphenation to mass spectrometry for extracellular vesicle analysis.
Pocsfalvi G; Stanly C; Fiume I; Vékey K
J Chromatogr A; 2016 Mar; 1439():26-41. PubMed ID: 26830636
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive analysis of tara tannins by reversed-phase and hydrophilic interaction chromatography coupled to ion mobility and high-resolution mass spectrometry.
Venter P; Pasch H; de Villiers A
Anal Bioanal Chem; 2019 Sep; 411(24):6329-6341. PubMed ID: 31222409
[TBL] [Abstract][Full Text] [Related]
53. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
54. Reversed-phase liquid chromatography-mass spectrometry of site-specific chemical modifications in intact immunoglobulin molecules and their fragments.
Ren D; Pipes G; Xiao G; Kleemann GR; Bondarenko PV; Treuheit MJ; Gadgil HS
J Chromatogr A; 2008 Feb; 1179(2):198-204. PubMed ID: 18096172
[TBL] [Abstract][Full Text] [Related]
55. Multidimensional LC-MS with
Verscheure L; Detremmerie S; Stals H; De Vos J; Sandra P; Lynen F; Borgions F; Sandra K
J Chromatogr A; 2024 Jul; 1726():464947. PubMed ID: 38724406
[TBL] [Abstract][Full Text] [Related]
56. Development of a 3D-LC/MS Workflow for Fast, Automated, and Effective Characterization of Glycosylation Patterns of Biotherapeutic Products.
Camperi J; Dai L; Guillarme D; Stella C
Anal Chem; 2020 Mar; 92(6):4357-4363. PubMed ID: 32079391
[TBL] [Abstract][Full Text] [Related]
57. Analysis of 3-(acetylamino)-6-aminoacridine-derivatized oligosaccharides from recombinant monoclonal antibodies by liquid chromatography-mass spectrometry.
Clarke A; Harmon B; DeFelippis MR
Anal Biochem; 2009 Jul; 390(2):209-11. PubMed ID: 19379705
[TBL] [Abstract][Full Text] [Related]
58. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species.
Sarrut M; Fekete S; Janin-Bussat MC; Colas O; Guillarme D; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():91-102. PubMed ID: 27426265
[TBL] [Abstract][Full Text] [Related]
59. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.
Dillon TM; Bondarenko PV; Rehder DS; Pipes GD; Kleemann GR; Ricci MS
J Chromatogr A; 2006 Jul; 1120(1-2):112-20. PubMed ID: 16448656
[TBL] [Abstract][Full Text] [Related]
60. Automated middle-up approach for the characterization of biotherapeutic products by combining on-line hinge-specific digestion with RPLC-HRMS analysis.
Camperi J; Guillarme D; Lei M; Stella C
J Pharm Biomed Anal; 2020 Apr; 182():113130. PubMed ID: 32004773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
